GABRIELLE RAMPAZI: Open Payments
NPI 1639910961 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,022 in 45 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $202 · 2025 $1,022
Food & beverage: $1,022
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $141 |
| Mannkind Corporation | 4 | $103 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $98 |
| Lilly USA, LLC | 4 | $84 |
| Xeris Pharmaceuticals, Inc. | 4 | $81 |
| ABBVIE INC. | 3 | $76 |
| Novo Nordisk Inc | 3 | $74 |
| Corcept Therapeutics | 4 | $69 |
| Ascendis Pharma Endocrinology Inc | 2 | $55 |
| Abbott Laboratories | 2 | $43 |
Products named: JARDIANCE, TEPEZZA, AFREZZA, GVOKE HYPOPEN, Korlym, Yorvipath, Wegovy, FREESTYLE LIBRE 3.
Industry payments across NV — which companies pay providers there.
